menu
    • menu

    Company profile for AI Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are an AI-driven company with a unique ability to match drugs to indications and prosecute through clinical development. AI Therapeutics’ revolutionary approach to drug discovery and development has advanced three drugs into clinical trials. AI Therapeutics was founded in 2013 as LAM Therapeutics with a mission to advance the clinical development of new therapies to treat Lymphangioleiomyomatosis (LAM) and other diseas...
    We are an AI-driven company with a unique ability to match drugs to indications and prosecute through clinical development. AI Therapeutics’ revolutionary approach to drug discovery and development has advanced three drugs into clinical trials. AI Therapeutics was founded in 2013 as LAM Therapeutics with a mission to advance the clinical development of new therapies to treat Lymphangioleiomyomatosis (LAM) and other diseases. In 2018 we changed our name to AI Therapeutics. Working with a dedicated team of scientific, clinical, and drug development experts, AI Therapeutics is pioneering deep learning-based AI to outsmart cancer.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AI TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    530 Old Whitfield Street Guilford, CT 06437
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.ai-therapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/aitherapeutics/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/aitherapeutics

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Codexis Unveils Enzymatic RNAi Therapeutics Synthesis Data
    Codexis Unveils Enzymatic RNAi Therapeutics Synthesis Data

    14 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/14/2981613/24825/en/Codexis-Unveils-Pioneering-Enzymatic-Synthesis-Data-to-Enable-the-Future-Manufacturing-of-RNAi-Therapeutics.html

    GLOBENEWSWIRE
    14 Nov 2024
    Share Share
    AI Therapeutics Announces Name Change to OrphAI Therapeutics
    AI Therapeutics Announces Name Change to OrphAI Therapeutics

    28 Sep 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/09/28/2751457/0/en/AI-Therapeutics-Announces-Name-Change-to-OrphAI-Therapeutics.html

    GLOBENEWSWIRE
    28 Sep 2023
    Share Share
    AI Therapeutics Announces Initiation of a Pha2 Trial of LAM-001 for (PAH)
    AI Therapeutics Announces Initiation of a Pha2 Trial of LAM-001 for (PAH)

    31 Aug 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/08/31/2735462/0/en/AI-Therapeutics-Announces-Initiation-of-a-Phase-2-Clinical-Trial-of-LAM-001-for-Treatment-of-Pulmonary-Arterial-Hypertension-PAH.html

    GLOBENEWSWIRE
    31 Aug 2023
    Share Share
    AI Therapeutics Announces Investigator Initiated Phase 2 Trial to Study LAM-001
    AI Therapeutics Announces Investigator Initiated Phase 2 Trial to Study LAM-001

    18 Aug 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/08/18/2728101/0/en/AI-Therapeutics-Announces-Investigator-Initiated-Phase-2-Trial-at-UCSF-to-Study-LAM-001-in-Patients-With-Bronchiolitis-Obliterans-Syndrome-BOS-Post-Lung-Transplant.html

    GLOBENEWSWIRE
    18 Aug 2023
    Share Share
    AI Therapeutics Appoints David Scheer as Chairman of the Board of Directors
    AI Therapeutics Appoints David Scheer as Chairman of the Board of Directors

    12 Jul 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/07/12/2703751/0/en/AI-Therapeutics-Announces-Appointment-of-Biotechnology-Industry-Leader-David-Scheer-as-Chairman-of-the-Board-of-Directors.html

    GLOBENEWSWIRE
    12 Jul 2023
    Share Share
    AI Therapeutics Announces Poster Presentation at the 2023 ATSIC
    AI Therapeutics Announces Poster Presentation at the 2023 ATSIC

    09 May 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/05/09/2664682/0/en/AI-Therapeutics-Announces-Poster-Presentation-at-the-2023-American-Thoracic-Society-International-Conference.html

    GLOBENEWSWIRE
    09 May 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search